📊 VASO Key Takeaways
Is VASO Corp (VASO) a Good Investment?
VASO Corp maintains a fortress balance sheet with 35M cash and negligible debt, supporting positive 8.7M free cash flow despite operating losses. However, severe operational inefficiency—evidenced by -3.2% operating margin despite 61.4% gross margin—combined with minimal 2.7% revenue growth and share dilution suggests fundamental business restructuring is needed before the balance sheet strength can translate into shareholder value.
Why Buy VASO Corp Stock? VASO Key Strengths
- Strong 61.4% gross margin demonstrates competitive product positioning and pricing power in electromedical apparatus market
- Fortress balance sheet with 35M cash (39.6% of total assets), 1.59x current ratio, and negligible debt (15K long-term) providing substantial financial flexibility and downside protection
- Positive 8.7M free cash flow generation despite operating loss indicates underlying cash-generative capability despite operational challenges
VASO Stock Risks: VASO Corp Investment Risks
- Severe operational inefficiency with 64.7% operating expense ratio despite 61.4% gross margin, creating structural -3.2% operating margin and indicating fundamental cost control failures
- Minimal 2.7% YoY revenue growth with only 1.8% net margin leaves minimal room for error and suggests limited competitive advantages or market expansion
- Share dilution evident from flat EPS (0% YoY) despite 65% net income growth indicates value destruction through dilutive capital raises and excessive share count
Key Metrics to Watch
- Operating margin trend and SG&A expense reduction initiatives to narrow 57.6M gap between gross profit and operating loss
- Revenue growth acceleration and product pipeline success in specialty electromedical segments
- Share dilution rate trajectory and insider buying activity as confidence indicator for operational turnaround
VASO Corp (VASO) Financial Metrics & Key Ratios
💡 AI Analyst Insight
VASO Corp presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
VASO Profit Margin, ROE & Profitability Analysis
VASO vs Healthcare Sector: How VASO Corp Compares
How VASO Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is VASO Corp Stock Overvalued? VASO Valuation Analysis 2026
Based on fundamental analysis, VASO Corp has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
VASO Corp Balance Sheet: VASO Debt, Cash & Liquidity
VASO Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: VASO Corp's revenue has shown modest growth of 2% over the 5-year period. The most recent EPS of $0.01 reflects profitable operations.
VASO Revenue Growth, EPS Growth & YoY Performance
VASO Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2024 | $19.4M | $454.0K | $0.01 |
| Q2 2024 | $20.2M | -$18.0K | $0.00 |
| Q1 2022 | $16.5M | -$344.0K | N/A |
| Q3 2021 | $17.4M | -$643.0K | N/A |
| Q2 2021 | $16.1M | -$643.0K | N/A |
| Q1 2021 | $16.5M | -$643.0K | N/A |
| Q3 2020 | $17.5M | $562.0K | $0.00 |
| Q2 2020 | $16.3M | -$597.0K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
VASO Corp Dividends, Buybacks & Capital Allocation
VASO SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for VASO Corp (CIK: 0000839087)
📋 Recent SEC Filings
❓ Frequently Asked Questions about VASO
What is the AI rating for VASO?
VASO Corp (VASO) has an AI rating of HOLD with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are VASO's key strengths?
Claude: Strong 61.4% gross margin demonstrates competitive product positioning and pricing power in electromedical apparatus market. Fortress balance sheet with 35M cash (39.6% of total assets), 1.59x current ratio, and negligible debt (15K long-term) providing substantial financial flexibility and downside protection.
What are the risks of investing in VASO?
Claude: Severe operational inefficiency with 64.7% operating expense ratio despite 61.4% gross margin, creating structural -3.2% operating margin and indicating fundamental cost control failures. Minimal 2.7% YoY revenue growth with only 1.8% net margin leaves minimal room for error and suggests limited competitive advantages or market expansion.
What is VASO's revenue and growth?
VASO Corp reported revenue of $89.1M.
Does VASO pay dividends?
VASO Corp does not currently pay dividends.
Where can I find VASO SEC filings?
Official SEC filings for VASO Corp (CIK: 0000839087) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is VASO's EPS?
VASO Corp has a diluted EPS of $0.01.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is VASO a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, VASO Corp has a HOLD rating with 72% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is VASO stock overvalued or undervalued?
Valuation metrics for VASO: ROE of 5.3% (sector avg: 15%), net margin of 1.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy VASO stock in 2026?
Our dual AI analysis gives VASO Corp a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is VASO's free cash flow?
VASO Corp's operating cash flow is $9.3M, with capital expenditures of $566.0K. FCF margin is 9.8%.
How does VASO compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 1.8% (avg: 12%), ROE 5.3% (avg: 15%), current ratio 1.59 (avg: 2).